Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC Atg7-IN-2 | 2226227-75-2 | 99.3% | 376.35 | 50 MG
SDP

Catalog No. 5000359820
Encompass_Preferred

ATG7-IN-2 (compound 1) is a potent ATG7 inhibitor, with an IC50 of 0.089 μM. It inhibits the autophagy marker LC3B. This product is for research use only and is not sold to patients.

  • Potent ATG7 inhibitor with an IC50 of 0.089 μM.
  • Inhibits autophagy marker LC3B.
  • Inhibits the formation of the ATG7-ATG8 thioester in HEK293 cells with an IC50 of 0.335 μM.
  • Suppresses LC3B lipidation in H4 cells with an IC50 of 2.6 μM.
  • Reduces cell viability in H1650 cells with an EC50 of 2.6 μM.

Catalog No. 50-003-59820 Supplier Medchemexpress LLC Supplier No. HY14613050MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

ATG7-IN-2 (compound 1) is a potent ATG7 inhibitor, with an IC50 of 0.089 μM. It inhibits the autophagy marker LC3B. This product is for research use only and is not sold to patients.

  • Potent ATG7 inhibitor with an IC50 of 0.089 μM.
  • Inhibits autophagy marker LC3B.
  • Inhibits the formation of the ATG7-ATG8 thioester in HEK293 cells with an IC50 of 0.335 μM.
  • Suppresses LC3B lipidation in H4 cells with an IC50 of 2.6 μM.
  • Reduces cell viability in H1650 cells with an EC50 of 2.6 μM.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.